Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Duodenal Ulcer
|
33 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.810 | 1.000 | 1 | 2012 | 2012 | ||||||
Venous Thromboembolism
|
408 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.800 | 1.000 | 3 | 2009 | 2012 | ||||||
von Willebrand's factor (lab test)
|
427 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.800 | 1.000 | 2 | 2013 | 2017 | ||||||
Graves Disease
|
352 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||
Pancreatic carcinoma
|
322 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.740 | 1.000 | 6 | 2009 | 2018 | ||||||
Malignant neoplasm of pancreas
|
277 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.740 | 1.000 | 4 | 2009 | 2015 | ||||||
Ischemic stroke
|
704 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.720 | 1.000 | 3 | 2013 | 2018 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.710 | 1.000 | 2 | 2018 | 2019 | ||||||
Alkaline phosphatase measurement
|
79 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Blood Protein Measurement
|
2575 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
C-reactive protein measurement
|
624 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Homocysteine measurement
|
33 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Malaria
|
148 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Nasopharyngeal carcinoma
|
320 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||
Peripheral Arterial Diseases
|
128 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
Protein measurement
|
422 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Pseudocholinesterase Measurement
|
568 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
Serum albumin measurement
|
3282 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Venous Thrombosis
|
218 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Cerebrovascular accident
|
591 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.020 | 2 | 2013 | 2017 | |||||||
Malignant Neoplasms
|
1641 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||
Primary malignant neoplasm
|
1374 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||
Adenocarcinoma
|
168 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Breast Carcinoma
|
2793 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.010 | 1 | 2012 | 2012 | |||||||
Cardioembolic stroke
|
28 | 0.689 | 0.520 | 9 | 133273813 | intron variant | C/T | snv | 0.010 | 1 | 2013 | 2013 |